心臓マーカー世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > 心臓マーカー世界市場の発展状況と動向 2024-2030

英文タイトル： Global Cardiac Marker Market Insights, Forecast to 2030

レポートID：274244
発表時期：2024-04-25
訪問回数：766
ページ数：109
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：134
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

サンプルお申込み

お問い合わせ

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、心臓マーカーの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に心臓マーカー市場を分類しています。

本レポートでは世界の心臓マーカー市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：HyTest、Abbott、Roche Diagnostics、BG Medicine、Biomerieux、Critical Diagnostics、DiaDexus、Response Biomedical、Siemens Healthcare、Singulex、Thermo Scientific、Trinity Biotech、Sunfory、Lee BioSolutions

レポートは心臓マーカーの主要生産者を調査し、主要地域や国の消費状況も提供します。心臓マーカーの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

用途別の市場セグメント：
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

本レポートの詳細内容
本レポートは、世界の心臓マーカー市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて心臓マーカー市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の心臓マーカー生産量、成長率、市場シェアを調査している。

二. 消費面では、心臓マーカーの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの心臓マーカー売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の心臓マーカー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本心臓マーカーのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：心臓マーカーのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：心臓マーカーの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける心臓マーカーの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章心臓マーカーメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：心臓マーカーの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：心臓マーカーの主要メーカーの概要を提供し、製品の説明と仕様、心臓マーカーの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：心臓マーカーの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

The global Cardiac Marker market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Cardiac Marker include HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical and Siemens Healthcare, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Cardiac Marker, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cardiac Marker, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Cardiac Marker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cardiac Marker sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Cardiac Marker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Cardiac Marker sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including HyTest, Abbott, Roche Diagnostics, BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, Response Biomedical and Siemens Healthcare, etc.

Market Segmentation
By Company
HyTest
Abbott
Roche Diagnostics
BG Medicine
Biomerieux
Critical Diagnostics
DiaDexus
Response Biomedical
Siemens Healthcare
Singulex
Thermo Scientific
Trinity Biotech
Sunfory
Lee BioSolutions

Segment by Type
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Others (hs-CRP, D-Dimer, etc.)

Segment by Application
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Cardiac Marker in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cardiac Marker sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Cardiac Marker Product Introduction
1.2 Market by Type
1.2.1 Global Cardiac Marker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Creatine kinase (CK) MB
1.2.3 Troponin (cTnI and cTnT)
1.2.4 BNP & NT-proBNP
1.2.5 Myogloblin
1.2.6 Others (hs-CRP, D-Dimer, etc.)
1.3 Market by Application
1.3.1 Global Cardiac Marker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Cardiac Marker Sales Estimates and Forecasts 2019-2030
2.2 Global Cardiac Marker Revenue by Region
2.2.1 Global Cardiac Marker Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Cardiac Marker Revenue by Region (2019-2024)
2.2.3 Global Cardiac Marker Revenue by Region (2025-2030)
2.2.4 Global Cardiac Marker Revenue Market Share by Region (2019-2030)
2.3 Global Cardiac Marker Sales Estimates and Forecasts 2019-2030
2.4 Global Cardiac Marker Sales by Region
2.4.1 Global Cardiac Marker Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Cardiac Marker Sales by Region (2019-2024)
2.4.3 Global Cardiac Marker Sales by Region (2025-2030)
2.4.4 Global Cardiac Marker Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Cardiac Marker Sales by Manufacturers
3.1.1 Global Cardiac Marker Sales by Manufacturers (2019-2024)
3.1.2 Global Cardiac Marker Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cardiac Marker in 2023
3.2 Global Cardiac Marker Revenue by Manufacturers
3.2.1 Global Cardiac Marker Revenue by Manufacturers (2019-2024)
3.2.2 Global Cardiac Marker Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Cardiac Marker Revenue in 2023
3.3 Global Key Players of Cardiac Marker, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Cardiac Marker Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cardiac Marker, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cardiac Marker, Product Offered and Application
3.8 Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Cardiac Marker Sales by Type
4.1.1 Global Cardiac Marker Historical Sales by Type (2019-2024)
4.1.2 Global Cardiac Marker Forecasted Sales by Type (2025-2030)
4.1.3 Global Cardiac Marker Sales Market Share by Type (2019-2030)
4.2 Global Cardiac Marker Revenue by Type
4.2.1 Global Cardiac Marker Historical Revenue by Type (2019-2024)
4.2.2 Global Cardiac Marker Forecasted Revenue by Type (2025-2030)
4.2.3 Global Cardiac Marker Revenue Market Share by Type (2019-2030)
4.3 Global Cardiac Marker Price by Type
4.3.1 Global Cardiac Marker Price by Type (2019-2024)
4.3.2 Global Cardiac Marker Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Cardiac Marker Sales by Application
5.1.1 Global Cardiac Marker Historical Sales by Application (2019-2024)
5.1.2 Global Cardiac Marker Forecasted Sales by Application (2025-2030)
5.1.3 Global Cardiac Marker Sales Market Share by Application (2019-2030)
5.2 Global Cardiac Marker Revenue by Application
5.2.1 Global Cardiac Marker Historical Revenue by Application (2019-2024)
5.2.2 Global Cardiac Marker Forecasted Revenue by Application (2025-2030)
5.2.3 Global Cardiac Marker Revenue Market Share by Application (2019-2030)
5.3 Global Cardiac Marker Price by Application
5.3.1 Global Cardiac Marker Price by Application (2019-2024)
5.3.2 Global Cardiac Marker Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Cardiac Marker Market Size by Type
6.1.1 US & Canada Cardiac Marker Sales by Type (2019-2030)
6.1.2 US & Canada Cardiac Marker Revenue by Type (2019-2030)
6.2 US & Canada Cardiac Marker Market Size by Application
6.2.1 US & Canada Cardiac Marker Sales by Application (2019-2030)
6.2.2 US & Canada Cardiac Marker Revenue by Application (2019-2030)
6.3 US & Canada Cardiac Marker Market Size by Country
6.3.1 US & Canada Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Cardiac Marker Sales by Country (2019-2030)
6.3.3 US & Canada Cardiac Marker Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Cardiac Marker Market Size by Type
7.1.1 Europe Cardiac Marker Sales by Type (2019-2030)
7.1.2 Europe Cardiac Marker Revenue by Type (2019-2030)
7.2 Europe Cardiac Marker Market Size by Application
7.2.1 Europe Cardiac Marker Sales by Application (2019-2030)
7.2.2 Europe Cardiac Marker Revenue by Application (2019-2030)
7.3 Europe Cardiac Marker Market Size by Country
7.3.1 Europe Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Cardiac Marker Sales by Country (2019-2030)
7.3.3 Europe Cardiac Marker Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Cardiac Marker Market Size
8.1.1 China Cardiac Marker Sales (2019-2030)
8.1.2 China Cardiac Marker Revenue (2019-2030)
8.2 China Cardiac Marker Market Size by Application
8.2.1 China Cardiac Marker Sales by Application (2019-2030)
8.2.2 China Cardiac Marker Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Cardiac Marker Market Size by Type
9.1.1 Asia Cardiac Marker Sales by Type (2019-2030)
9.1.2 Asia Cardiac Marker Revenue by Type (2019-2030)
9.2 Asia Cardiac Marker Market Size by Application
9.2.1 Asia Cardiac Marker Sales by Application (2019-2030)
9.2.2 Asia Cardiac Marker Revenue by Application (2019-2030)
9.3 Asia Cardiac Marker Sales by Region
9.3.1 Asia Cardiac Marker Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Cardiac Marker Revenue by Region (2019-2030)
9.3.3 Asia Cardiac Marker Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cardiac Marker Market Size by Type
10.1.1 Middle East, Africa and Latin America Cardiac Marker Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Cardiac Marker Market Size by Application
10.2.1 Middle East, Africa and Latin America Cardiac Marker Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Cardiac Marker Sales by Country
10.3.1 Middle East, Africa and Latin America Cardiac Marker Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Cardiac Marker Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 HyTest
11.1.1 HyTest Company Information
11.1.2 HyTest Overview
11.1.3 HyTest Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 HyTest Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 HyTest Recent Developments
11.2 Abbott
11.2.1 Abbott Company Information
11.2.2 Abbott Overview
11.2.3 Abbott Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbott Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Information
11.3.2 Roche Diagnostics Overview
11.3.3 Roche Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Roche Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Diagnostics Recent Developments
11.4 BG Medicine
11.4.1 BG Medicine Company Information
11.4.2 BG Medicine Overview
11.4.3 BG Medicine Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 BG Medicine Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BG Medicine Recent Developments
11.5 Biomerieux
11.5.1 Biomerieux Company Information
11.5.2 Biomerieux Overview
11.5.3 Biomerieux Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biomerieux Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biomerieux Recent Developments
11.6 Critical Diagnostics
11.6.1 Critical Diagnostics Company Information
11.6.2 Critical Diagnostics Overview
11.6.3 Critical Diagnostics Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Critical Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Critical Diagnostics Recent Developments
11.7 DiaDexus
11.7.1 DiaDexus Company Information
11.7.2 DiaDexus Overview
11.7.3 DiaDexus Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 DiaDexus Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 DiaDexus Recent Developments
11.8 Response Biomedical
11.8.1 Response Biomedical Company Information
11.8.2 Response Biomedical Overview
11.8.3 Response Biomedical Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Response Biomedical Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Response Biomedical Recent Developments
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Information
11.9.2 Siemens Healthcare Overview
11.9.3 Siemens Healthcare Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Siemens Healthcare Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Siemens Healthcare Recent Developments
11.10 Singulex
11.10.1 Singulex Company Information
11.10.2 Singulex Overview
11.10.3 Singulex Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Singulex Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Singulex Recent Developments
11.11 Thermo Scientific
11.11.1 Thermo Scientific Company Information
11.11.2 Thermo Scientific Overview
11.11.3 Thermo Scientific Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Thermo Scientific Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Thermo Scientific Recent Developments
11.12 Trinity Biotech
11.12.1 Trinity Biotech Company Information
11.12.2 Trinity Biotech Overview
11.12.3 Trinity Biotech Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Trinity Biotech Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Trinity Biotech Recent Developments
11.13 Sunfory
11.13.1 Sunfory Company Information
11.13.2 Sunfory Overview
11.13.3 Sunfory Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Sunfory Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sunfory Recent Developments
11.14 Lee BioSolutions
11.14.1 Lee BioSolutions Company Information
11.14.2 Lee BioSolutions Overview
11.14.3 Lee BioSolutions Cardiac Marker Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Lee BioSolutions Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lee BioSolutions Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Cardiac Marker Industry Chain Analysis
12.2 Cardiac Marker Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cardiac Marker Production Mode & Process
12.4 Cardiac Marker Sales and Marketing
12.4.1 Cardiac Marker Sales Channels
12.4.2 Cardiac Marker Distributors
12.5 Cardiac Marker Customers

13 Market Dynamics
13.1 Cardiac Marker Industry Trends
13.2 Cardiac Marker Market Drivers
13.3 Cardiac Marker Market Challenges
13.4 Cardiac Marker Market Restraints

14 Key Findings in The Global Cardiac Marker Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Cardiac Marker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Creatine kinase (CK) MB
    Table 3. Major Manufacturers of Troponin (cTnI and cTnT)
    Table 4. Major Manufacturers of BNP & NT-proBNP
    Table 5. Major Manufacturers of Myogloblin
    Table 6. Major Manufacturers of Others (hs-CRP, D-Dimer, etc.)
    Table 7. Global Cardiac Marker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global Cardiac Marker Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 9. Global Cardiac Marker Revenue by Region (2019-2024) & (US$ Million)
    Table 10. Global Cardiac Marker Revenue by Region (2025-2030) & (US$ Million)
    Table 11. Global Cardiac Marker Revenue Market Share by Region (2019-2024)
    Table 12. Global Cardiac Marker Revenue Market Share by Region (2025-2030)
    Table 13. Global Cardiac Marker Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Cardiac Marker Sales by Region (2019-2024) & (K Doses)
    Table 15. Global Cardiac Marker Sales by Region (2025-2030) & (K Doses)
    Table 16. Global Cardiac Marker Sales Market Share by Region (2019-2024)
    Table 17. Global Cardiac Marker Sales Market Share by Region (2025-2030)
    Table 18. Global Cardiac Marker Sales by Manufacturers (2019-2024) & (K Doses)
    Table 19. Global Cardiac Marker Sales Share by Manufacturers (2019-2024)
    Table 20. Global Cardiac Marker Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 21. Global Cardiac Marker Revenue Share by Manufacturers (2019-2024)
    Table 22. Global Key Players of Cardiac Marker, Industry Ranking, 2022 VS 2023 VS 2024
    Table 23. Cardiac Marker Price by Manufacturers 2019-2024 (USD/Dose)
    Table 24. Global Cardiac Marker Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Marker as of 2023)
    Table 26. Global Key Manufacturers of Cardiac Marker, Manufacturing Base Distribution and Headquarters
    Table 27. Global Key Manufacturers of Cardiac Marker, Product Offered and Application
    Table 28. Global Key Manufacturers of Cardiac Marker, Date of Enter into This Industry
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 31. Global Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 32. Global Cardiac Marker Sales Share by Type (2019-2024)
    Table 33. Global Cardiac Marker Sales Share by Type (2025-2030)
    Table 34. Global Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 35. Global Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 36. Global Cardiac Marker Revenue Share by Type (2019-2024)
    Table 37. Global Cardiac Marker Revenue Share by Type (2025-2030)
    Table 38. Cardiac Marker Price by Type (2019-2024) & (USD/Dose)
    Table 39. Global Cardiac Marker Price Forecast by Type (2025-2030) & (USD/Dose)
    Table 40. Global Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 41. Global Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 42. Global Cardiac Marker Sales Share by Application (2019-2024)
    Table 43. Global Cardiac Marker Sales Share by Application (2025-2030)
    Table 44. Global Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 45. Global Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 46. Global Cardiac Marker Revenue Share by Application (2019-2024)
    Table 47. Global Cardiac Marker Revenue Share by Application (2025-2030)
    Table 48. Cardiac Marker Price by Application (2019-2024) & (USD/Dose)
    Table 49. Global Cardiac Marker Price Forecast by Application (2025-2030) & (USD/Dose)
    Table 50. US & Canada Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 51. US & Canada Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 52. US & Canada Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 53. US & Canada Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 54. US & Canada Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 55. US & Canada Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 56. US & Canada Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 57. US & Canada Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 58. US & Canada Cardiac Marker Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 59. US & Canada Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
    Table 60. US & Canada Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
    Table 61. US & Canada Cardiac Marker Sales by Country (2019-2024) & (K Doses)
    Table 62. US & Canada Cardiac Marker Sales by Country (2025-2030) & (K Doses)
    Table 63. Europe Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 64. Europe Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 65. Europe Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 66. Europe Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 67. Europe Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 68. Europe Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 69. Europe Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 70. Europe Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 71. Europe Cardiac Marker Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 72. Europe Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
    Table 73. Europe Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
    Table 74. Europe Cardiac Marker Sales by Country (2019-2024) & (K Doses)
    Table 75. Europe Cardiac Marker Sales by Country (2025-2030) & (K Doses)
    Table 76. China Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 77. China Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 78. China Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 79. China Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 80. China Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 81. China Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 82. China Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 83. China Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 84. Asia Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 85. Asia Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 86. Asia Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 87. Asia Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 88. Asia Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 89. Asia Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 90. Asia Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 91. Asia Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 92. Asia Cardiac Marker Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 93. Asia Cardiac Marker Revenue by Region (2019-2024) & (US$ Million)
    Table 94. Asia Cardiac Marker Revenue by Region (2025-2030) & (US$ Million)
    Table 95. Asia Cardiac Marker Sales by Region (2019-2024) & (K Doses)
    Table 96. Asia Cardiac Marker Sales by Region (2025-2030) & (K Doses)
    Table 97. Middle East, Africa and Latin America Cardiac Marker Sales by Type (2019-2024) & (K Doses)
    Table 98. Middle East, Africa and Latin America Cardiac Marker Sales by Type (2025-2030) & (K Doses)
    Table 99. Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2019-2024) & (US$ Million)
    Table 100. Middle East, Africa and Latin America Cardiac Marker Revenue by Type (2025-2030) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Cardiac Marker Sales by Application (2019-2024) & (K Doses)
    Table 102. Middle East, Africa and Latin America Cardiac Marker Sales by Application (2025-2030) & (K Doses)
    Table 103. Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Cardiac Marker Revenue by Application (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Cardiac Marker Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 106. Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2019-2024) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Cardiac Marker Revenue by Country (2025-2030) & (US$ Million)
    Table 108. Middle East, Africa and Latin America Cardiac Marker Sales by Country (2019-2024) & (K Doses)
    Table 109. Middle East, Africa and Latin America Cardiac Marker Sales by Country (2025-2030) & (K Doses)
    Table 110. HyTest Company Information
    Table 111. HyTest Description and Major Businesses
    Table 112. HyTest Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 113. HyTest Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. HyTest Recent Developments
    Table 115. Abbott Company Information
    Table 116. Abbott Description and Major Businesses
    Table 117. Abbott Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 118. Abbott Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Abbott Recent Developments
    Table 120. Roche Diagnostics Company Information
    Table 121. Roche Diagnostics Description and Major Businesses
    Table 122. Roche Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 123. Roche Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Roche Diagnostics Recent Developments
    Table 125. BG Medicine Company Information
    Table 126. BG Medicine Description and Major Businesses
    Table 127. BG Medicine Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 128. BG Medicine Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. BG Medicine Recent Developments
    Table 130. Biomerieux Company Information
    Table 131. Biomerieux Description and Major Businesses
    Table 132. Biomerieux Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 133. Biomerieux Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Biomerieux Recent Developments
    Table 135. Critical Diagnostics Company Information
    Table 136. Critical Diagnostics Description and Major Businesses
    Table 137. Critical Diagnostics Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 138. Critical Diagnostics Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Critical Diagnostics Recent Developments
    Table 140. DiaDexus Company Information
    Table 141. DiaDexus Description and Major Businesses
    Table 142. DiaDexus Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 143. DiaDexus Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. DiaDexus Recent Developments
    Table 145. Response Biomedical Company Information
    Table 146. Response Biomedical Description and Major Businesses
    Table 147. Response Biomedical Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 148. Response Biomedical Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Response Biomedical Recent Developments
    Table 150. Siemens Healthcare Company Information
    Table 151. Siemens Healthcare Description and Major Businesses
    Table 152. Siemens Healthcare Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 153. Siemens Healthcare Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Siemens Healthcare Recent Developments
    Table 155. Singulex Company Information
    Table 156. Singulex Description and Major Businesses
    Table 157. Singulex Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 158. Singulex Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Singulex Recent Developments
    Table 160. Thermo Scientific Company Information
    Table 161. Thermo Scientific Description and Major Businesses
    Table 162. Thermo Scientific Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 163. Thermo Scientific Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Thermo Scientific Recent Developments
    Table 165. Trinity Biotech Company Information
    Table 166. Trinity Biotech Description and Major Businesses
    Table 167. Trinity Biotech Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 168. Trinity Biotech Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Trinity Biotech Recent Developments
    Table 170. Sunfory Company Information
    Table 171. Sunfory Description and Major Businesses
    Table 172. Sunfory Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 173. Sunfory Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Sunfory Recent Developments
    Table 175. Lee BioSolutions Company Information
    Table 176. Lee BioSolutions Description and Major Businesses
    Table 177. Lee BioSolutions Cardiac Marker Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
    Table 178. Lee BioSolutions Cardiac Marker Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Lee BioSolutions Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Cardiac Marker Distributors List
    Table 183. Cardiac Marker Customers List
    Table 184. Cardiac Marker Market Trends
    Table 185. Cardiac Marker Market Drivers
    Table 186. Cardiac Marker Market Challenges
    Table 187. Cardiac Marker Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cardiac Marker Product Picture
    Figure 2. Global Cardiac Marker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Cardiac Marker Market Share by Type in 2023 & 2030
    Figure 4. Creatine kinase (CK) MB Product Picture
    Figure 5. Troponin (cTnI and cTnT) Product Picture
    Figure 6. BNP & NT-proBNP Product Picture
    Figure 7. Myogloblin Product Picture
    Figure 8. Others (hs-CRP, D-Dimer, etc.) Product Picture
    Figure 9. Global Cardiac Marker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Cardiac Marker Market Share by Application in 2023 & 2030
    Figure 11. Myocardial Infarction
    Figure 12. Congestive Heart Failure
    Figure 13. Acute Coronary Syndrome
    Figure 14. Atherosclerosis
    Figure 15. Others
    Figure 16. Cardiac Marker Report Years Considered
    Figure 17. Global Cardiac Marker Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Cardiac Marker Revenue 2019-2030 (US$ Million)
    Figure 19. Global Cardiac Marker Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 20. Global Cardiac Marker Revenue Market Share by Region (2019-2030)
    Figure 21. Global Cardiac Marker Sales 2019-2030 ((K Doses)
    Figure 22. Global Cardiac Marker Sales Market Share by Region (2019-2030)
    Figure 23. US & Canada Cardiac Marker Sales YoY (2019-2030) & (K Doses)
    Figure 24. US & Canada Cardiac Marker Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Cardiac Marker Sales YoY (2019-2030) & (K Doses)
    Figure 26. Europe Cardiac Marker Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. China Cardiac Marker Sales YoY (2019-2030) & (K Doses)
    Figure 28. China Cardiac Marker Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Asia (excluding China) Cardiac Marker Sales YoY (2019-2030) & (K Doses)
    Figure 30. Asia (excluding China) Cardiac Marker Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. Middle East, Africa and Latin America Cardiac Marker Sales YoY (2019-2030) & (K Doses)
    Figure 32. Middle East, Africa and Latin America Cardiac Marker Revenue YoY (2019-2030) & (US$ Million)
    Figure 33. The Cardiac Marker Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 34. The Top 5 and 10 Largest Manufacturers of Cardiac Marker in the World: Market Share by Cardiac Marker Revenue in 2023
    Figure 35. Global Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 36. Global Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 37. Global Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 38. Global Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 39. Global Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 40. US & Canada Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 41. US & Canada Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 42. US & Canada Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 43. US & Canada Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 44. US & Canada Cardiac Marker Revenue Share by Country (2019-2030)
    Figure 45. US & Canada Cardiac Marker Sales Share by Country (2019-2030)
    Figure 46. U.S. Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 47. Canada Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 48. Europe Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 49. Europe Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 50. Europe Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 51. Europe Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 52. Europe Cardiac Marker Revenue Share by Country (2019-2030)
    Figure 53. Europe Cardiac Marker Sales Share by Country (2019-2030)
    Figure 54. Germany Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 55. France Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 56. U.K. Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 57. Italy Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 58. Russia Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 59. China Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 60. China Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 61. China Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 62. China Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 63. Asia Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 64. Asia Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 65. Asia Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 66. Asia Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 67. Asia Cardiac Marker Revenue Share by Region (2019-2030)
    Figure 68. Asia Cardiac Marker Sales Share by Region (2019-2030)
    Figure 69. Japan Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 70. South Korea Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 71. China Taiwan Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 72. Southeast Asia Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 73. India Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 74. Middle East, Africa and Latin America Cardiac Marker Sales Market Share by Type (2019-2030)
    Figure 75. Middle East, Africa and Latin America Cardiac Marker Revenue Market Share by Type (2019-2030)
    Figure 76. Middle East, Africa and Latin America Cardiac Marker Sales Market Share by Application (2019-2030)
    Figure 77. Middle East, Africa and Latin America Cardiac Marker Revenue Market Share by Application (2019-2030)
    Figure 78. Middle East, Africa and Latin America Cardiac Marker Revenue Share by Country (2019-2030)
    Figure 79. Middle East, Africa and Latin America Cardiac Marker Sales Share by Country (2019-2030)
    Figure 80. Brazil Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 81. Mexico Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 82. Turkey Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 83. Israel Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 84. GCC Countries Cardiac Marker Revenue (2019-2030) & (US$ Million)
    Figure 85. Cardiac Marker Value Chain
    Figure 86. Cardiac Marker Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed

産業カテゴリー